496 related articles for article (PubMed ID: 16829749)
1. Contrast media and nephropathy: findings from systematic analysis and Food and Drug Administration reports of adverse effects.
Solomon R; Dumouchel W
Invest Radiol; 2006 Aug; 41(8):651-60. PubMed ID: 16829749
[TBL] [Abstract][Full Text] [Related]
2. The role of osmolality in the incidence of contrast-induced nephropathy: a systematic review of angiographic contrast media in high risk patients.
Solomon R
Kidney Int; 2005 Nov; 68(5):2256-63. PubMed ID: 16221227
[TBL] [Abstract][Full Text] [Related]
3. Antipsychotics, glycemic disorders, and life-threatening diabetic events: a Bayesian data-mining analysis of the FDA adverse event reporting system (1968-2004).
DuMouchel W; Fram D; Yang X; Mahmoud RA; Grogg AL; Engelhart L; Ramaswamy K
Ann Clin Psychiatry; 2008; 20(1):21-31. PubMed ID: 18297583
[TBL] [Abstract][Full Text] [Related]
4. Contrast-induced nephropathy--prevention and risk reduction.
Lameire NH
Nephrol Dial Transplant; 2006 Jun; 21(6):i11-23. PubMed ID: 16723348
[TBL] [Abstract][Full Text] [Related]
5. N-acetylcysteine and contrast-induced nephropathy: a meta-analysis of 13 randomized trials.
Zagler A; Azadpour M; Mercado C; Hennekens CH
Am Heart J; 2006 Jan; 151(1):140-5. PubMed ID: 16368307
[TBL] [Abstract][Full Text] [Related]
6. What are radiologists doing to prevent contrast-induced nephropathy (CIN) compared with measures supported by current evidence? A survey of European radiologists on CIN associated with computed tomography.
Fishman EK; Reddan D
Acta Radiol; 2008 Apr; 49(3):310-20. PubMed ID: 18365820
[TBL] [Abstract][Full Text] [Related]
7. The relative renal safety of iodixanol compared with low-osmolar contrast media: a meta-analysis of randomized controlled trials.
Reed M; Meier P; Tamhane UU; Welch KB; Moscucci M; Gurm HS
JACC Cardiovasc Interv; 2009 Jul; 2(7):645-54. PubMed ID: 19628188
[TBL] [Abstract][Full Text] [Related]
8. The safety and cost-effectiveness of low osmolar contrast media. Can economic analysis determine the real worth of a new technology?
Henry DA; Evans DB; Robertson J
Med J Aust; 1991 Jun; 154(11):766-72. PubMed ID: 1828529
[TBL] [Abstract][Full Text] [Related]
9. Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials.
Heinrich MC; Häberle L; Müller V; Bautz W; Uder M
Radiology; 2009 Jan; 250(1):68-86. PubMed ID: 19092091
[TBL] [Abstract][Full Text] [Related]
10. [Contrast-induced nephropathy in coronarography of patients with type 2 diabetes mellitus: risk factors, prognostic significance, prophylactic approaches].
Shamkhalova MSh; Zaĭtseva NV; Kurumova KO; Shestakova MV; Deev AD; Matskeplishvili ST; Tugeeva EF; Buziashvili IuI
Ter Arkh; 2009; 81(8):36-42. PubMed ID: 19799198
[TBL] [Abstract][Full Text] [Related]
11. Contrast media induced nephropathy: definition, incidence, outcome, pathophysiology, risk factors and prevention.
Feldkamp T; Kribben A
Minerva Med; 2008 Apr; 99(2):177-96. PubMed ID: 18431326
[TBL] [Abstract][Full Text] [Related]
12. Effect of nonionic radiocontrast agents on the occurrence of contrast-induced nephropathy in patients with mild-moderate chronic renal insufficiency: pooled analysis of the randomized trials.
Sharma SK; Kini A
Catheter Cardiovasc Interv; 2005 Jul; 65(3):386-93. PubMed ID: 15926184
[TBL] [Abstract][Full Text] [Related]
13. Comparative Effect of Contrast Media Type on the Incidence of Contrast-Induced Nephropathy: A Systematic Review and Meta-analysis.
Eng J; Wilson RF; Subramaniam RM; Zhang A; Suarez-Cuervo C; Turban S; Choi MJ; Sherrod C; Hutfless S; Iyoha EE; Bass EB
Ann Intern Med; 2016 Mar; 164(6):417-24. PubMed ID: 26830055
[TBL] [Abstract][Full Text] [Related]
14. Contrast-induced nephropathy in patients with diabetes mellitus between iso- and low-osmolar contrast media: A meta-analysis of full-text prospective, randomized controlled trials.
Han XF; Zhang XX; Liu KM; Tan H; Zhang Q
PLoS One; 2018; 13(3):e0194330. PubMed ID: 29558481
[TBL] [Abstract][Full Text] [Related]
15. Radiologists' knowledge and perceptions of the impact of contrast-induced nephropathy and its risk factors when performing computed tomography examinations: a survey of European radiologists.
Reddan D; Fishman EK
Eur J Radiol; 2008 May; 66(2):235-45. PubMed ID: 17728089
[TBL] [Abstract][Full Text] [Related]
16. Iodixanol versus low-osmolar contrast media for prevention of contrast induced nephropathy: meta-analysis of randomized, controlled trials.
From AM; Al Badarin FJ; McDonald FS; Bartholmai BJ; Cha SS; Rihal CS
Circ Cardiovasc Interv; 2010 Aug; 3(4):351-8. PubMed ID: 20647563
[TBL] [Abstract][Full Text] [Related]
17. Renal protective effects and the prevention of contrast-induced nephropathy by atrial natriuretic peptide.
Morikawa S; Sone T; Tsuboi H; Mukawa H; Morishima I; Uesugi M; Morita Y; Numaguchi Y; Okumura K; Murohara T
J Am Coll Cardiol; 2009 Mar; 53(12):1040-6. PubMed ID: 19298916
[TBL] [Abstract][Full Text] [Related]
18. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables.
Dangas G; Iakovou I; Nikolsky E; Aymong ED; Mintz GS; Kipshidze NN; Lansky AJ; Moussa I; Stone GW; Moses JW; Leon MB; Mehran R
Am J Cardiol; 2005 Jan; 95(1):13-9. PubMed ID: 15619387
[TBL] [Abstract][Full Text] [Related]
19. Contrast-induced nephropathy among Israeli hospitalized patients: incidence, risk factors, length of stay and mortality.
Shema L; Ore L; Geron R; Kristal B
Isr Med Assoc J; 2009 Aug; 11(8):460-4. PubMed ID: 19891232
[TBL] [Abstract][Full Text] [Related]
20. [Tolerability of nonionic contrast media--results of a multicenter double blind study].
Schmiedel E
Aktuelle Radiol; 1992 May; 2(3):148-52. PubMed ID: 1610929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
